𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Preemptive therapy for cytomegalovirus based on real-time measurement of viral load in liver transplant recipients

✍ Scribed by Hsin-Yun Sun; Thomas V. Cacciarelli; Marilyn M. Wagener; Nina Singh


Book ID
116940298
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
162 KB
Volume
23
Category
Article
ISSN
0966-3274

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Valganciclovir as preemptive therapy for
✍ Nina Singh; Cheryl Wannstedt; Lois Keyes; Debra Mayher; Lisa Tickerhoof; Mohamed πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 82 KB

The efficacy of valganciclovir as preemptive therapy for the prevention of cytomegalovirus (CMV) disease and its impact on indirect sequelae of CMV were assessed in recipient-negative/donor-positive (RΟͺ/DΟ©) liver transplant recipients. Of 187 consecutive liver transplant recipients at our institutio

Clinically-based determination of safe D
✍ Daniele Lilleri; Fausto Baldanti; Marta Gatti; Francesca Rovida; Luca Dossena; S πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 101 KB

## Abstract Transplantation Centers using human cytomegalovirus (HCMV) antigenemia‐based preemptive therapy will need to replace in the near future the antigenemia assay with a more standardized and automatable assay, such as a molecular assay quantifying HCMV DNA in blood (DNAemia). Thus, in view